Condition: LAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A) · Merosin Deficient CMD (Full or Partial) · Merosin Deficient Congenital Muscular Dystrophy · Sponsor: Hospital Universitari Vall d'Hebron Research Institute
The objective of this natural history study is to comprehensively characterize the disease progression and clinical features of LAMA2-related dystrophies (LAMA2-RD) in the pediatric population. The study aims to establish a well-defined cohort of patients in Spain, enabling long-term follow-up and facilitating recruitment for future clinical trials.
This description comes directly from the study's public registry record.
David Gómez-Andrés · +34934893156 · david.gomezandres@vallhebron.cat
Always discuss trial participation with your own doctor first.
| University Hospital Vall d'Hebron | Barcelona, Barcelona, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06924125